Glenview's Larry Robbins on Butterfly Network Deal, Amazon

The transcript discusses the Butterfly ultrasound device, its innovative approach to healthcare, and its financial strategy to achieve profitability by 2024. It highlights the impact of the pandemic on healthcare, strategic partnerships, and market trends. The discussion also covers Amazon's entry into pharmaceuticals and its potential impact. The conversation concludes with insights into market outlook and investment strategies.

How does the text describe the impact of the pandemic on healthcare access?

What are the anticipated trends in healthcare utilization post-pandemic?

What role does Amazon play in the pharmaceutical distribution landscape according to the text?

What are the expected outcomes for the pharmaceutical distributors mentioned?